Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 345

1.

Association of Serum Uromodulin With ESKD and Kidney Function Decline in the Elderly: The Cardiovascular Health Study.

Steubl D, Buzkova P, Garimella PS, Ix JH, Devarajan P, Bennett MR, Chaves PHM, Shlipak MG, Bansal N, Sarnak MJ.

Am J Kidney Dis. 2019 May 22. pii: S0272-6386(19)30664-X. doi: 10.1053/j.ajkd.2019.02.024. [Epub ahead of print]

PMID:
31128770
2.

Inhibition of fibronectin polymerization alleviates kidney injury due to ischemia-reperfusion.

Bowers SLK, Davis-Rodriguez S, Thomas ZM, Rudomanova V, Bacon WC, Beiersdorfer A, Ma Q, Devarajan P, Blaxall BC.

Am J Physiol Renal Physiol. 2019 Jun 1;316(6):F1293-F1298. doi: 10.1152/ajprenal.00117.2019. Epub 2019 Apr 24.

PMID:
31017009
3.

Identification of Urinary CD44 and Prosaposin as Specific Biomarkers of Urinary Tract Infections in Children With Neurogenic Bladders.

Forster CS, Haffey WD, Bennett M, Greis KD, Devarajan P.

Biomark Insights. 2019 Mar 15;14:1177271919835570. doi: 10.1177/1177271919835570. eCollection 2019.

4.

Association of serum uromodulin with mortality and cardiovascular disease in the elderly-the Cardiovascular Health Study.

Steubl D, Buzkova P, Garimella PS, Ix JH, Devarajan P, Bennett MR, Chaves PHM, Shlipak MG, Bansal N, Sarnak MJ.

Nephrol Dial Transplant. 2019 Mar 21. pii: gfz008. doi: 10.1093/ndt/gfz008. [Epub ahead of print]

PMID:
30903163
5.

Original Antigenic Sin: Friend or Foe in Developing a Broadly Cross-Reactive Vaccine to Influenza?

Devarajan P, Swain SL.

Cell Host Microbe. 2019 Mar 13;25(3):354-355. doi: 10.1016/j.chom.2019.02.009.

PMID:
30870620
6.

Proteomic profiling of urine: implications for lupus nephritis.

Aljaberi N, Bennett M, Brunner HI, Devarajan P.

Expert Rev Proteomics. 2019 Apr;16(4):303-313. doi: 10.1080/14789450.2019.1592681. Epub 2019 Mar 18.

PMID:
30855196
7.

Enhancing Curcumin Oral Bioavailability Through Nanoformulations.

Ipar VS, Dsouza A, Devarajan PV.

Eur J Drug Metab Pharmacokinet. 2019 Feb 15. doi: 10.1007/s13318-019-00545-z. [Epub ahead of print]

PMID:
30771095
8.

Polymeric curcumin nanoparticles by a facile in situ method for macrophage targeted delivery.

Jahagirdar PS, Gupta PK, Kulkarni SP, Devarajan PV.

Bioeng Transl Med. 2018 Nov 5;4(1):141-151. doi: 10.1002/btm2.10112. eCollection 2019 Jan.

9.

Haptoglobin degradation product as a novel serum biomarker for hematopoietic stem cell transplant-associated thrombotic microangiopathy.

Schuh MP, Bennett MR, Lane A, Jodele S, Laskin BL, Devarajan P.

Pediatr Nephrol. 2019 May;34(5):865-871. doi: 10.1007/s00467-018-4178-x. Epub 2018 Dec 19.

PMID:
30569313
10.

Discovery of SERPINA3 as a candidate urinary biomarker of lupus nephritis activity.

Turnier JL, Brunner HI, Bennett M, Aleed A, Gulati G, Haffey WD, Thornton S, Wagner M, Devarajan P, Witte D, Greis KD, Aronow B.

Rheumatology (Oxford). 2019 Feb 1;58(2):321-330. doi: 10.1093/rheumatology/key301.

PMID:
30285245
11.

Association of infections and venous thromboembolism in hospitalized children with nephrotic syndrome.

Carpenter SL, Goldman J, Sherman AK, Selewski DT, Kallash M, Tran CL, Seamon M, Katsoufis C, Ashoor I, Hernandez J, Supe-Markovina K, D'alessandri-Silva C, DeJesus-Gonzalez N, Vasylyeva TL, Formeck C, Woll C, Gbadegesin R, Geier P, Devarajan P, Smoyer WE, Kerlin BA, Rheault MN.

Pediatr Nephrol. 2019 Feb;34(2):261-267. doi: 10.1007/s00467-018-4072-6. Epub 2018 Sep 7.

PMID:
30194664
12.

Urine biomarkers of chronic kidney damage and renal functional decline in childhood-onset systemic lupus erythematosus.

Brunner HI, Gulati G, Klein-Gitelman MS, Rouster-Stevens KA, Tucker L, Ardoin SP, Onel KB, Mainville R, Turnier J, Aydin POA, Witte D, Huang B, Bennett MR, Devarajan P.

Pediatr Nephrol. 2019 Jan;34(1):117-128. doi: 10.1007/s00467-018-4049-5. Epub 2018 Aug 29.

PMID:
30159624
13.

Exploring Peyer's Patch Uptake as a Strategy for Targeted Lung Delivery of Polymeric Rifampicin Nanoparticles.

Bachhav SS, Dighe VD, Devarajan PV.

Mol Pharm. 2018 Oct 1;15(10):4434-4445. doi: 10.1021/acs.molpharmaceut.8b00382. Epub 2018 Aug 28.

PMID:
30106591
14.

Urinary neutrophil gelatinase-associated lipocalin-guided risk assessment for major adverse kidney events after open-heart surgery.

Albert C, Albert A, Bellomo R, Kropf S, Devarajan P, Westphal S, Baraki H, Kutschka I, Butter C, Haase M, Haase-Fielitz A.

Biomark Med. 2018 Sep;12(9):975-985. doi: 10.2217/bmm-2018-0071. Epub 2018 Aug 8.

PMID:
30088425
15.

NMR-based urine metabolic profiling and immunohistochemistry analysis of nephron changes in a mouse model of hypoxia-induced acute kidney injury.

Chihanga T, Ruby HN, Ma Q, Bashir S, Devarajan P, Kennedy MA.

Am J Physiol Renal Physiol. 2018 Oct 1;315(4):F1159-F1173. doi: 10.1152/ajprenal.00500.2017. Epub 2018 Jul 11.

PMID:
29993280
16.

Pathogen Recognition by CD4 Effectors Drives Key Effector and Most Memory Cell Generation Against Respiratory Virus.

Devarajan P, Jones MC, Kugler-Umana O, Vong AM, Xia J, Swain SL.

Front Immunol. 2018 Mar 26;9:596. doi: 10.3389/fimmu.2018.00596. eCollection 2018. Review.

17.

Kidney injury biomarkers 5 years after AKI due to pediatric cardiac surgery.

Greenberg JH, Devarajan P, Thiessen-Philbrook HR, Krawczeski C, Parikh CR, Zappitelli M; TRIBE-AKI Consortium.

Pediatr Nephrol. 2018 Jun;33(6):1069-1077. doi: 10.1007/s00467-018-3888-4. Epub 2018 Mar 6.

18.

Biomarkers of AKI Progression after Pediatric Cardiac Surgery.

Greenberg JH, Zappitelli M, Jia Y, Thiessen-Philbrook HR, de Fontnouvelle CA, Wilson FP, Coca S, Devarajan P, Parikh CR.

J Am Soc Nephrol. 2018 May;29(5):1549-1556. doi: 10.1681/ASN.2017090989. Epub 2018 Feb 22.

19.

The future role of proteomics in the understanding of acute kidney injury.

Bennett MR, Devarajan P.

Expert Rev Proteomics. 2018 Mar;15(3):191-192. doi: 10.1080/14789450.2018.1443007. Epub 2018 Feb 23. No abstract available.

PMID:
29471684
20.

Initiation of inflammatory tumorigenesis by CTLA4 insufficiency due to type 2 cytokines.

Miska J, Lui JB, Toomer KH, Devarajan P, Cai X, Houghton J, Lopez DM, Abreu MT, Wang G, Chen Z.

J Exp Med. 2018 Mar 5;215(3):841-858. doi: 10.1084/jem.20171971. Epub 2018 Jan 26.

21.

Impact of Near Real-Time Urine Neutrophil Gelatinase-Associated Lipocalin Assessment on Clinical Practice.

Varnell CD Jr, Goldstein SL, Devarajan P, Basu RK.

Kidney Int Rep. 2017 Jun 3;2(6):1243-1249. doi: 10.1016/j.ekir.2017.05.012. eCollection 2017 Nov. No abstract available.

22.

Erratum to 'Rifampicin Lipid-Polymer hybrid nanoparticles (LIPOMER) for enhanced Peyer's patch uptake' [International Journal of Pharmaceutics 532 (2017) 612-622].

Bachhav SS, Dighe VD, Kotak D, Devarajan PV.

Int J Pharm. 2017 Dec 20;534(1-2):387-390. doi: 10.1016/j.ijpharm.2017.11.013. No abstract available.

PMID:
29129341
23.

Enhanced antimalalarial activity of a prolonged release in situ gel of arteether-lumefantrine in a murine model.

Dawre S, Pathak S, Sharma S, Devarajan PV.

Eur J Pharm Biopharm. 2018 Feb;123:95-107. doi: 10.1016/j.ejpb.2017.11.002. Epub 2017 Nov 6.

PMID:
29122736
24.

Preoperative levels of urinary uromodulin predict acute kidney injury after pediatric cardiopulmonary bypass surgery.

Bennett MR, Pyles O, Ma Q, Devarajan P.

Pediatr Nephrol. 2018 Mar;33(3):521-526. doi: 10.1007/s00467-017-3823-0. Epub 2017 Oct 23.

25.

Effects of age and gender on reference levels of biomarkers comprising the pediatric Renal Activity Index for Lupus Nephritis (p-RAIL).

Bennett MR, Ma Q, Ying J, Devarajan P, Brunner H.

Pediatr Rheumatol Online J. 2017 Oct 13;15(1):74. doi: 10.1186/s12969-017-0202-0.

26.

Association of serum albumin levels with kidney function decline and incident chronic kidney disease in elders.

Lang J, Katz R, Ix JH, Gutierrez OM, Peralta CA, Parikh CR, Satterfield S, Petrovic S, Devarajan P, Bennett M, Fried LF, Cummings SR, Sarnak MJ, Shlipak MG.

Nephrol Dial Transplant. 2018 Jun 1;33(6):986-992. doi: 10.1093/ndt/gfx229.

27.

NMR spectroscopy and electron microscopy identification of metabolic and ultrastructural changes to the kidney following ischemia-reperfusion injury.

Chihanga T, Ma Q, Nicholson JD, Ruby HN, Edelmann RE, Devarajan P, Kennedy MA.

Am J Physiol Renal Physiol. 2018 Feb 1;314(2):F154-F166. doi: 10.1152/ajprenal.00363.2017. Epub 2017 Oct 4.

28.

Rifampicin Lipid-Polymer hybrid nanoparticles (LIPOMER) for enhanced Peyer's patch uptake.

Bachhav SS, Dighe VD, Kotak D, Devarajan PV.

Int J Pharm. 2017 Oct 30;532(1):612-622. doi: 10.1016/j.ijpharm.2017.09.040. Epub 2017 Sep 19. Erratum in: Int J Pharm. 2017 Dec 20;534(1-2):387-390.

PMID:
28935258
29.

First-stage palliation strategy for univentricular heart disease may impact risk for acute kidney injury.

Goldstein BH, Goldstein SL, Devarajan P, Zafar F, Kwiatkowski DM, Marino BS, Morales DLS, Krawczeski CD, Cooper DS.

Cardiol Young. 2018 Jan;28(1):93-100. doi: 10.1017/S1047951117001640. Epub 2017 Sep 11.

PMID:
28889816
30.

Interleukin-8 and Tumor Necrosis Factor Predict Acute Kidney Injury After Pediatric Cardiac Surgery.

de Fontnouvelle CA, Greenberg JH, Thiessen-Philbrook HR, Zappitelli M, Roth J, Kerr KF, Devarajan P, Shlipak M, Coca S, Parikh CR; TRIBE-AKI Consortium.

Ann Thorac Surg. 2017 Dec;104(6):2072-2079. doi: 10.1016/j.athoracsur.2017.04.038. Epub 2017 Aug 16.

31.

Urinary biomarkers of cell cycle arrest are delayed predictors of acute kidney injury after pediatric cardiopulmonary bypass.

Dong L, Ma Q, Bennett M, Devarajan P.

Pediatr Nephrol. 2017 Dec;32(12):2351-2360. doi: 10.1007/s00467-017-3748-7. Epub 2017 Jul 28.

PMID:
28755073
32.

Subclinical Kidney Injury in Children Receiving Nonsteroidal Anti-Inflammatory Drugs After Cardiac Surgery.

Nehus E, Kaddourah A, Bennett M, Pyles O, Devarajan P.

J Pediatr. 2017 Oct;189:175-180. doi: 10.1016/j.jpeds.2017.06.045. Epub 2017 Jul 13.

33.

Increased susceptibility to structural acute kidney injury in a mouse model of presymptomatic cardiomyopathy.

Pleasant L, Ma Q, Devarajan M, Parameswaran P, Drake K, Siroky B, Shay-Winkler K, Robbins J, Devarajan P.

Am J Physiol Renal Physiol. 2017 Sep 1;313(3):F699-F705. doi: 10.1152/ajprenal.00505.2016. Epub 2017 Jul 5.

34.

Urine Biomarkers to Predict Response to Lupus Nephritis Therapy in Children and Young Adults.

Brunner HI, Bennett MR, Gulati G, Abulaban K, Klein-Gitelman MS, Ardoin SP, Tucker LB, Rouster-Stevens KA, Witte D, Ying J, Devarajan P.

J Rheumatol. 2017 Aug;44(8):1239-1248. doi: 10.3899/jrheum.161128. Epub 2017 Jun 15.

PMID:
28620062
35.

Acute kidney injury: emerging pharmacotherapies in current clinical trials.

Benoit SW, Devarajan P.

Pediatr Nephrol. 2018 May;33(5):779-787. doi: 10.1007/s00467-017-3695-3. Epub 2017 Jun 10. Review.

36.

Losartan for the nephropathy of sickle cell anemia: A phase-2, multicenter trial.

Quinn CT, Saraf SL, Gordeuk VR, Fitzhugh CD, Creary SE, Bodas P, George A, Raj AB, Nero AC, Terrell CE, McCord L, Lane A, Ackerman HC, Yang Y, Niss O, Taylor MD, Devarajan P, Malik P.

Am J Hematol. 2017 Sep;92(9):E520-E528. doi: 10.1002/ajh.24810. Epub 2017 Jul 19.

37.

A Novel Biomarker Panel to Identify Steroid Resistance in Childhood Idiopathic Nephrotic Syndrome.

Bennett MR, Pleasant L, Haffner C, Ma Q, Haffey WD, Ying J, Wagner M, Greis KD, Devarajan P.

Biomark Insights. 2017 Mar 8;12:1177271917695832. doi: 10.1177/1177271917695832. eCollection 2017.

38.

Pediatric acute kidney injury: prevalence, impact and management challenges.

Ciccia E, Devarajan P.

Int J Nephrol Renovasc Dis. 2017 Mar 29;10:77-84. doi: 10.2147/IJNRD.S103785. eCollection 2017. Review.

39.

Biomarkers for Early Acute Kidney Injury Diagnosis and Severity Prediction: A Pilot Multicenter Canadian Study of Children Admitted to the ICU.

Palermo J, Dart AB, De Mello A, Devarajan P, Gottesman R, Garcia Guerra G, Hansen G, Joffe AR, Mammen C, Majesic N, Morgan C, Skippen P, Pizzi M, Palijan A, Zappitelli M.

Pediatr Crit Care Med. 2017 Jun;18(6):e235-e244. doi: 10.1097/PCC.0000000000001183.

40.

Urine biomarkers of acute kidney injury in noncritically ill, hospitalized children treated with chemotherapy.

Sterling M, Al-Ismaili Z, McMahon KR, Piccioni M, Pizzi M, Mottes T, Lands LC, Abish S, Fleming AJ, Bennett MR, Palijan A, Devarajan P, Goldstein SL, O'Brien MM, Zappitelli M.

Pediatr Blood Cancer. 2017 Oct;64(10). doi: 10.1002/pbc.26538. Epub 2017 Apr 18.

PMID:
28417544
41.

Association of urinary uromodulin with kidney function decline and mortality: the health ABC study
.

Garimella PS, Katz R, Ix JH, Fried LF, Kritchevsky SB, Devarajan P, Bennett MR, Parikh CR, Shlipak MG, Harris TB, Gutiérrez OM, Sarnak MJ.

Clin Nephrol. 2017 Jun;87(6):278-286. doi: 10.5414/CN109005.

42.

Design and Methods of the Pan-Canadian Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Nephrotoxicity Study: A Prospective Observational Cohort Study.

McMahon KR, Rod Rassekh S, Schultz KR, Pinsk M, Blydt-Hansen T, Mammen C, Tsuyuki RT, Devarajan P, Cuvelier GD, Mitchell LG, Baruchel S, Palijan A, Carleton BC, Ross CJ, Zappitelli M; Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Research Group.

Can J Kidney Health Dis. 2017 Feb 16;4:2054358117690338. doi: 10.1177/2054358117690338. eCollection 2017.

43.

IL-6 Production by TLR-Activated APC Broadly Enhances Aged Cognate CD4 Helper and B Cell Antibody Responses In Vivo.

Brahmakshatriya V, Kuang Y, Devarajan P, Xia J, Zhang W, Vong AM, Swain SL.

J Immunol. 2017 Apr 1;198(7):2819-2833. doi: 10.4049/jimmunol.1601119. Epub 2017 Mar 1.

44.

In situ hybrid nano drug delivery system (IHN-DDS) of antiretroviral drug for simultaneous targeting to multiple viral reservoirs: An in vivo proof of concept.

Jindal AB, Bachhav SS, Devarajan PV.

Int J Pharm. 2017 Apr 15;521(1-2):196-203. doi: 10.1016/j.ijpharm.2017.02.024. Epub 2017 Feb 14.

PMID:
28229943
45.

Acute kidney injury: Acute kidney injury: still misunderstood and misdiagnosed.

Devarajan P.

Nat Rev Nephrol. 2017 Mar;13(3):137-138. doi: 10.1038/nrneph.2017.9. Epub 2017 Feb 6. No abstract available.

46.

Docosahexaenoic acid-mediated, targeted and sustained brain delivery of curcumin microemulsion.

Shinde RL, Devarajan PV.

Drug Deliv. 2017 Nov;24(1):152-161. doi: 10.1080/10717544.2016.1233593.

PMID:
28156175
47.

Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma.

Pranatharthiharan S, Patel MD, Malshe VC, Pujari V, Gorakshakar A, Madkaikar M, Ghosh K, Devarajan PV.

Drug Deliv. 2017 Nov;24(1):20-29. doi: 10.1080/10717544.2016.1225856.

PMID:
28155331
48.

NKG2C/E Marks the Unique Cytotoxic CD4 T Cell Subset, ThCTL, Generated by Influenza Infection.

Marshall NB, Vong AM, Devarajan P, Brauner MD, Kuang Y, Nayar R, Schutten EA, Castonguay CH, Berg LJ, Nutt SL, Swain SL.

J Immunol. 2017 Feb 1;198(3):1142-1155. doi: 10.4049/jimmunol.1601297. Epub 2016 Dec 28.

49.

Urinary Uromodulin and Risk of Urinary Tract Infections: The Cardiovascular Health Study.

Garimella PS, Bartz TM, Ix JH, Chonchol M, Shlipak MG, Devarajan P, Bennett MR, Sarnak MJ.

Am J Kidney Dis. 2017 Jun;69(6):744-751. doi: 10.1053/j.ajkd.2016.08.022. Epub 2016 Oct 28.

50.

Microwave-Assisted Development of Orally Disintegrating Tablets by Direct Compression.

Kande KV, Kotak DJ, Degani MS, Kirsanov D, Legin A, Devarajan PV.

AAPS PharmSciTech. 2017 Aug;18(6):2055-2066. doi: 10.1208/s12249-016-0683-z. Epub 2016 Dec 19.

PMID:
27995465

Supplemental Content

Loading ...
Support Center